Skip to content

Mesoblast Limited

MEOBF MESO

CIK 0001345099

← back to feed
Revenue (TTM)
$22.37M
+191.4% YoY Dec 2025
Net Income (TTM)
−$79.64M
−16.1% YoY Dec 2025
EPS Diluted (TTM)
−$0.16
+5.1% YoY Dec 2025
Gross Margin
77.1%
Dec 2025
Operating Margin
—
Dec 2025
Net Margin
-356.0%
Dec 2025
Free Cash Flow (TTM)
—
Dec 2025
Cash
$129.98M
Dec 2025
Total Debt
$5.02M
Dec 2025
Shares Outstanding
1.28B sh
Dec 2025

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings